The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), will present its white paper "RETHINKING Alzheimer’s disease: Detection and diagnosis". This paper is the first of EBC’s “RETHINKING Alzheimer’s disease” project, focused on improving Alzheimer’s disease detection, diagnosis, care and monitoring. The white paper particularly looks at how to detect and diagnose the disease at an earlier stage and what new care pathways need to be implemented to reach out to patients at that stage.
Advocacy event: RETHINKING Alzheimer’s disease: Detection and diagnosis
online